David González Vidal

Medical Doctor with proven track record of success in positions of responsibility in Medical Affairs in Biotech and Pharmaceutical Industry. Reputed for the design of innovative successful medical intelligence, medical education, medical services, sales force training and post-authorization research programs. Strong experience in Pharma and Biologics in Immunology, Inflammation, Cardiovascular, Nephrology, Oncology and Hematology and Bone Marrow Transplant, Diabetes, Dyslipidemia, Neurology and Pain, Dermatology, Infectious diseases, Vaccines, and Consumer Health among other therapeutic areas.

Supported and led high performance medical and cross-functional teams, successfully developing, leading, and executing the medical strategy. Recognized for building strong networks with KOLs and Medical Societies, driving medical education, scientific engagement, and regulatory support.

Medical Consultant at Multiple multinational companies (Present)

Currently collaborating with different multinational companies in the evaluation of Medical Affairs strategy and projects in oncology, hemato-oncology, diabetes, cardiovascular and neurology. Helping to build the Chair of Insomnia of the Universitat de Barcelona Neurology Department.

Medical Advisor / Medical Affairs Manager at Esteve Pharmaceuticals S.A.

Design, development, life-cycle management, pre-launch, launch and post-launch medical product strategy. Portfolio building and due diligence leading (Scientific area). Supporting development and execution of the Medical Affairs Strategy and programs.

• Creation, supervision and implementation of the medical education programs, services, activities, promotional materials, initial and continuous internal training of Commercial, MSLs, Market Access, etc.
• Creation, oversight, and scientific advice of medical education programs, services, marketing and sales activities and materials.
• Participation in the strategy and plans of the Business Units aligning to commercial growth drivers.
• Participation in the EUR Therapeutic Area Committees and the EUR Medical Affairs Committee.
• Scientific engagement with KOLs, evaluate and support local investigator-initiated research proposals.
• Interaction with Medical Societies and KOLs to ensure effective, trustful, and up-to-date communication.
• Provide environmental and competitive intelligence. valuable insight and feedback from the healthcare community on advancements in different TA, products and services, medical and scientific information.
• Attendance and participation in congresses to gain insight and feedback.
• Support market access in the interaction with the Health and Regulatory Authorities.
• Supervision of compliance with regulations, Farmaindustria, EFPIA, GCP, ethical codes and internal rules.
• Scientific symposium and Advisory Boards organization and participation as speaker or attendant.
• Initial and continuous internal training program of Commercial, MSLs, Market Access, etc.
• Participation and decision in Due Diligences and technical evaluations processes in Oncology.
• Co-building and review of regulatory documents (SPC, PI, Monography, Value Dossier etc.).
• Developed successful creative and innovative omnichannel interactive initial and continuous internal training programs, introducing attractive and engaging methods for commercial, MSLs, Market Access, etc.
• Co-designed, created, and built promotional materials, webinars, deliverables, omnichannel medical training services and medical education and scientific projects considered extremely innovative, attractive, and later adopted by other areas.
• Collaborate to rebuild and reshape Esteve's and other multinationals product and portfolio strategy.
• Created and successful implemented the medical launch strategy for new drugs, including Medical Learning Programs for HCPs, publications, pre-launch activities with Physicians, KOLs and Medical Societies involved.
• Hired, trained, and led the Medical Affairs team, coaching and defining plans, strategy, objectives and KPIs.
• Co-Built and co-led the Area Plan for a new Hospital Unit in Iberia (Spain+Portugal), achieving the reintroduction, training, and relaunch of drugs in the analgesia, hemato-oncology and oncology areas, previously considered of difficult management, exceeding the forecasts (275% of the 2022 sales target).
• Participated as representative for Spain in the Due Diligence of Oncotype® and the Due Diligence and Steering Committee of the global pivotal Phase III clinical trial of the Rencarex® monoclonal antibody for adjuvancy in Renal Clear Cell Cancer.
• Successfully systematized, exploited, and managed the bibliography of drugs and areas of interest, facilitating the medical knowledge and expertise on diseases and drugs of interest when needed, being considered the reference person for all new medical knowledge.
• Successfully led the integration of Riemser's UK/GER/FR/SPAIN portfolio and Medical Affairs area (an acquired company), building a Multinational Collaborative Medical Area to coordinate European projects, creating and co-leading the International Medical Committee and promoting the creation of the MSL European Committee.
• Redesigned and implemented the Esteve Medical Inquiries, Documentation, Donations, and KOL mapping and Validation systems for speakers and KOLs, expanding the External Expert network and developing / executing the External Expert Engagement and creating all the corresponding SOPs.
• Expanded local successful medical projects (registries, training projects, learning materials) to other countries (UK/GER/FR/SPAIN/PORTUGAL), by empowering its creators.
• Conceived and implemented national and international post-registration studies with innovative design, including Real World Evidence, DELPHI and Database mining trials.
• Participate in outcomes research/health economics engagements with national payers, Health Technology Assessment or regulatory agencies.

Medical Degree in Medicine – Universitat de Barcelona

Postgraduate in Medicine for the Pharmaceutical Industry – Universitat Autonoma de Barcelona

Master's in Molecular Oncology – Universidad Francisco de Vitoria

Master's in medical Documentation – INCANOP and Nixdorf-Siemens

Postgraduate in Marketing Management – EADA Business School

Postgraduate in Pharmaceutical Marketing – EADA Business School

Postgraduate in Geriatrics – Universitat de Barcelona